Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. - Kaufmann,M.; Bajetta,E.; Dirix,LY. (The Exemestane Study Group. J Clin Oncol, 2000)